Organogenesis Ownership | Who Owns Organogenesis?


OverviewForecastRevenueFinancialsChartTranscripts

Organogenesis Ownership Summary


Organogenesis is owned by 53.89% institutional investors, 46.93% insiders. Soleus capital management is the largest institutional shareholder, holding 9.56% of ORGO shares. Xtrackers S&P 500 Swap ETF 1C is the top mutual fund, with 2.56% of its assets in Organogenesis shares.

ORGO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrganogenesis53.89%46.93%-0.82%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Soleus capital management12.13M9.56%$51.20M
Morgan stanley11.80M9.30%$49.78M
First light asset management7.50M5.91%$31.64M
Vanguard group5.04M3.97%$21.25M
Blackrock5.09M3.86%$14.24M
Assenagon asset management4.85M3.83%$20.49M
Blackrock funding, inc. /de4.58M3.61%$19.35M
Deutsche bank ag\3.28M2.59%$13.86M
Dimensional fund advisors lp2.91M2.29%$12.28M
Acadian asset management1.75M1.38%$7.39M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
First light asset management7.50M2.98%$31.64M
Soleus capital management12.13M2.58%$51.20M
Highmark wealth management293.03K0.54%$1.24M
Wealth dimensions group407.96K0.35%$1.72M
Intrepid family office80.10K0.28%$338.02K
Kent lake capital151.91K0.19%$425.33K
Ajovista15.51K0.13%$43.44K
Pharvision advisers36.70K0.09%$154.88K
Capital square22.50K0.05%$96.75K
Assenagon asset management4.85M0.03%$20.49M

Top Buyers

HolderShares% AssetsChange
Assenagon asset management4.85M0.03%2.00M
First light asset management7.50M2.98%720.75K
Norges bank482.20K0.00%482.20K
Kent lake capital151.91K0.19%151.91K
Blackrock5.09M0.00%112.84K

Top Sellers

HolderShares% AssetsChange
Driehaus capital management---1.80M
Aqr capital management1.52M0.01%-1.19M
Acadian asset management1.75M0.01%-671.13K
Healthcare of ontario pension plan trust fund---649.90K
Lazard asset management---649.38K

New Positions

HolderShares% AssetsChangeValue
Norges bank482.20K0.00%482.20K$1.54M
Kent lake capital151.91K0.19%151.91K$425.33K
Pharvision advisers36.70K0.09%36.70K$154.88K
Balyasny asset management28.47K0.00%28.47K$104.21K
Nwam20.00K0.01%20.00K$81.60K

Sold Out

HolderChange
Assetmark-4.00
Ifp advisors-9.00
Northwestern mutual wealth management-10.00
Nelson, van denburg & campbell wealth management group-13.00
Us bancorp \de\-33.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025114-68,359,384-1.48%531.80%48-5.88%44-6.38%
Jun 30, 2025113-17.52%69,296,6277.39%542.09%50-32.43%472.17%
Mar 31, 202513613.33%64,503,6783.15%512.30%7417.46%4631.43%
Dec 31, 202443-61.61%19,203,473-69.76%140.63%19-64.15%11-71.79%
Sep 30, 2024112-4.27%63,509,8320.99%472.11%53-26.39%3930.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Xtrackers S&P 500 Swap ETF 1C3.25M2.56%-
Xtrackers S&P 500 2xLev Dly Swap ETF 1C2.41M1.82%-
Xtrackers S&P Global Infra Swap ETF 1C2.08M1.64%-
Vanguard Total Stock Mkt Idx Inv1.93M1.52%-42.63K
iShares Russell 2000 ETF1.71M1.34%-
Vanguard US Total Market Shares ETF1.59M1.25%-
Vanguard Institutional Extnd Mkt Idx Tr776.48K0.61%-350.98K
Heptagon Driehaus US Micro Cap Eq C$ Acc703.51K0.55%-9.64K
Fidelity Small Cap Index684.47K0.54%-10.13K
Vanguard Explorer Inv668.02K0.53%440.34K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 26, 2025NUSSDORF GLENN H Sell$994.29K
Nov 25, 2025NUSSDORF GLENN H Sell$63.83K
Nov 24, 2025NUSSDORF GLENN H Sell$534.00K
May 14, 2025NUSSDORF GLENN H Buy$775.04K
Jun 09, 2025NUSSDORF GLENN H Sell$14.55K

Insider Transactions Trends


DateBuySell
2025 Q4-3
2025 Q3--
2025 Q23-
2025 Q1-1
2024 Q4-7

ORGO Ownership FAQ


Who Owns Organogenesis?

Organogenesis shareholders are primarily institutional investors at 53.89%, followed by 46.93% insiders and -0.82% retail investors. The average institutional ownership in Organogenesis's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Organogenesis exceeds.

Who owns the most shares of Organogenesis?

Organogenesis’s largest shareholders are Soleus capital management (12.13M shares, 9.56%), Morgan stanley (11.8M shares, 9.30%), and First light asset management (7.5M shares, 5.91%). Together, they hold 24.77% of Organogenesis’s total shares outstanding.

Does Blackrock own Organogenesis?

Yes, BlackRock owns 3.86% of Organogenesis, totaling 5.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.24M$. In the last quarter, BlackRock increased its holdings by 112.84K shares, a 2.27% change.

Who is Organogenesis’s biggest shareholder by percentage of total assets invested?

First light asset management is Organogenesis’s biggest shareholder by percentage of total assets invested, with 2.98% of its assets in 7.5M Organogenesis shares, valued at 31.64M$.

Who is the top mutual fund holder of Organogenesis shares?

Xtrackers S&P 500 Swap ETF 1C is the top mutual fund holder of Organogenesis shares, with 2.56% of its total shares outstanding invested in 3.25M Organogenesis shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools